Updated Jul 16, 2026
Vivo Opportunity, LLC has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $402K.
| Role | 10% Owner |
|---|
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 147 | $1.55 | $228 |
| 2026-07-02 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 1.5K | $1.55 | $2K |
| 2026-07-02 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 398 | $1.55 | $617 |
| 2026-07-02 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 3.9K | $1.55 | $6K |
| 2026-07-02 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 55 | $1.54 | $85 |
| 2026-07-02 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 545 | $1.54 | $839 |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 3.0K | $1.52 | $5K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 29.5K | $1.52 | $45K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 5.0K | $1.57 | $8K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 50.0K | $1.57 | $78K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 618 | $1.57 | $970 |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 6.1K | $1.57 | $10K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 714 | $1.55 | $1K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 7.1K | $1.55 | $11K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 2.1K | $1.52 | $3K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 20.8K | $1.52 | $32K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 1.5K | $1.55 | $2K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 14.8K | $1.55 | $23K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 1.6K | $1.57 | $3K |
| 2026-06-11 | INM | InMed Pharmaceuticals Inc. | P — Open-market purchase | 16.2K | $1.57 | $25K |
Vivo Opportunity, LLC is a corporate insider — currently tracked as 10% Owner of InMed Pharmaceuticals Inc. (INM). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 24 open-market purchases ($402K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Vivo Opportunity, LLC profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.